Yakup Tanriver

PD Dr. med.
Principal Investigator
(Associated Member)

Department of Medicine, Renal Division
Medical Center – University of Freiburg
Hugstetter Str. 55
79106 Freiburg

Current Position

Attending Physician in Renal Medicine

Academic Education

1994 - 2001 Studies in Medicine, Charité, Universitätsmedizin Berlin

Advanced Qualifications

2020 Habilitation in Internal Medicine, University of Freiburg
2016 Board exam, Internal and Renal Medicine
2002 Doctoral degree in Medicine (Dr. med.), Charité, Universitätsmedizin Berlin

Postgraduate Positions

2016 - present Attending Physician in Renal Medicine, Renal Division, Medical Center - University of Freiburg
2010 - present Group Leader, Institute of Medical Microbiology and Renal Division, Medical Center - University of Freiburg
2009 - 2016 Resident, Renal Division, Medical Center - University of Freiburg
2005 - 2008 Postdoctoral Fellow, Immunoregulation Laboratory, King’s College, London, UK
2002 - 2005 Resident Department of Nephrology and Medical Intensive Care, Universitätsmedizin Charité, Berlin
2000 - 2002 MD thesis work in Transplantation Medicine at the Department of Nephrology and Medical Intensive Care, Universitätsmedizin Charité, Berlin

Link to all publications of Yakup Tanriver: PubMed

Publications on CRC 1453 funding

Thelen B, Schipperges V, Knörlein P, Hummel JF, Arnold F, …, Arnold SJ, Börries M, Tanriver Y. Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4+ T cells. Front Immunol (2023). Arnold F, Huzly D, Tanriver Y, Welte T. Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune disease. BMC Infect Dis (2022). Tanriver U, Emmerich F, Hummel JF, Jänigen B, Panning M, Arnold F, Tanriver Y. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study. Clin Transplant (2022).